Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
7,358
Views
62
CrossRef citations to date
0
Altmetric
Research Paper

A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma

Jiahang Songa Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China;b Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
,
Yuanyuan Sunb Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
,
Hui Caoa Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China;c Department of Thoracic Surgery, The Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China;d Department of Thoracic Surgery, The Pulmonary Nodule Diagnosis and Treatment Research Center of Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
,
Zhengcheng Liua Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China;c Department of Thoracic Surgery, The Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China;d Department of Thoracic Surgery, The Pulmonary Nodule Diagnosis and Treatment Research Center of Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
,
Lei Xia Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China;c Department of Thoracic Surgery, The Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China;d Department of Thoracic Surgery, The Pulmonary Nodule Diagnosis and Treatment Research Center of Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
,
Changqing Donga Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China;c Department of Thoracic Surgery, The Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China;d Department of Thoracic Surgery, The Pulmonary Nodule Diagnosis and Treatment Research Center of Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
,
Rusong Yanga Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China;c Department of Thoracic Surgery, The Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China;d Department of Thoracic Surgery, The Pulmonary Nodule Diagnosis and Treatment Research Center of Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
&
Ye Shia Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China;c Department of Thoracic Surgery, The Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China;d Department of Thoracic Surgery, The Pulmonary Nodule Diagnosis and Treatment Research Center of Nanjing Medical University, Nanjing, Jiangsu, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6133-6374View further author information
ORCID Icon show all
Pages 5932-5949 | Received 26 Jun 2021, Accepted 20 Aug 2021, Published online: 07 Sep 2021

Citations (62)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Xiaopeng Wang & Jing Yin. (2022) The biological function of the long non-coding RNA endogenous born avirus-like nucleoprotein in lung adenocarcinoma is mediated through the microRNA-655-3p/B-cell lymphoma-2 axis. Bioengineered 13:4, pages 10679-10690.
Read now
Yan Xiu, Shannan Cao, Ru Jiang & Yuming Zhou. (2022) lncRNA LINC01315 promotes malignancy of triple-negative breast cancer and predicts poor outcomes by modulating microRNA-876-5p/GRK5. Bioengineered 13:4, pages 10001-10009.
Read now
Zheng-Ying Jiang, Ming-Zhuo Liu, Zhong-Hua Fu, Xin-Cheng Liao, Bin Xu, Liang-Liang Shi, Jia-Qi Li & Guang-Hua Guo. (2022) The expression profile of lung long non-coding RNAs and mRNAs in a mouse model of smoke inhalation injury. Bioengineered 13:3, pages 4978-4990.
Read now
Zhenghai Bai, Fangshi Xu, Xiaodan Feng, Yuan Wu, Junhua Lv, Yu Shi & Honghong Pei. (2022) Pyroptosis regulators exert crucial functions in prognosis, progression and immune microenvironment of pancreatic adenocarcinoma: a bioinformatic and in vitro research. Bioengineered 13:1, pages 1717-1735.
Read now

Articles from other publishers (58)

Zixin Chen, Junjun Lin, Huifang Wang, Jing Wang & Zhou Zhang. (2024) Expression and clinical role of PRDX6 in lung adenocarcinoma . Journal of International Medical Research 52:3.
Crossref
Li-Hua Zhu, Jun Yang, Yun-Fei Zhang, Li Yan, Wan-Rong Lin & Wei-Qing Liu. (2024) Identification and validation of a pyroptosis-related prognostic model for colorectal cancer based on bulk and single-cell RNA sequencing data. World Journal of Clinical Oncology 15:2, pages 329-355.
Crossref
Ziwei Su, Yang Wang, Jialing Cao, Jie Ma, Guangzhao Wang, Huijuan Ren, Yihan Zhang, Kangliang Sheng, Xueying Zhu & Yongzhong Wang. (2024) Identification and validation of non‐coding RNA‐mediated high expression of IQGAP3 in poor prognosis of lung adenocarcinoma. The Journal of Gene Medicine 26:1.
Crossref
Jiamin Gu & Bo Ding. (2023) Cross‐talk of pyroptosis‐based subtypes, the development of a risk classifier and immune responses in cervical cancer. The Journal of Gene Medicine 26:1.
Crossref
Iman Abdullah Ramadhan, Luqman Rahman Sulaiman & Abbas Salihi. (2023) NOS3 and CTH gene mutations as new molecular markers for detection of lung adenocarcinoma. PeerJ 11, pages e16209.
Crossref
Dongxiao Ding, Liangbin Wang, Yunqiang Zhang, Ke Shi & Yaxing Shen. (2023) Machine learning developed a programmed cell death signature for predicting prognosis and immunotherapy benefits in lung adenocarcinoma. Translational Oncology 38, pages 101784.
Crossref
Pengpeng Zhang, Haotian Zhang, Junjie Tang, Qianhe Ren, Jieying Zhang, Hao Chi, Jingwen Xiong, Xiangjin Gong, Wei Wang, Haoran Lin, Jun Li & Chenjun Huang. (2023) The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy. Aging 15:19, pages 10305-10329.
Crossref
Zhiqiang Wu, Xiaofei Zeng, Hong Wang & Xianbo Wang. (2023) LncRNA ARAP1-AS1 contributes to lung adenocarcinoma development by targeting miR-8068 to upregulate CEACAM5. Cancer Biomarkers 38:2, pages 177-189.
Crossref
Peijun Liu, Long Zhou, Hao Chen, Yang He, Guangcai Li & Ke Hu. (2023) Identification of a novel intermittent hypoxia-related prognostic lncRNA signature and the ceRNA of lncRNA GSEC/miR-873-3p/EGLN3 regulatory axis in lung adenocarcinoma. PeerJ 11, pages e16242.
Crossref
Qijun Jiang, Junhao Zhou, Qi Chen, Yuliang Huang, Cheng Yang & Cundong Liu. (2023) Construction and experimental validation of a macrophage cell senescence-related gene signature to evaluate the prognosis, immunotherapeutic sensitivity, and chemotherapy response in bladder cancer. Functional & Integrative Genomics 23:3.
Crossref
Xinyu Chen, Xianji Zhu, Wenjun Yan, Luan Wang, Dongming Xue, Shouying Zhu, Jiajun Pan, Yufeng Li, Qixiang Zhao & Dong Han. (2023) Serum lncRNA THRIL predicts benign and malignant pulmonary nodules and promotes the progression of pulmonary malignancies. BMC Cancer 23:1.
Crossref
Yue-Ling Peng, Ya-Fang Dong, Li-Li Guo, Mu-Ye Li, Hui Liao & Rong-Shan Li. (2023) Identification and validation of a m7G-related lncRNA signature for predicting the prognosis and therapy response in hepatocellular carcinoma. PLOS ONE 18:8, pages e0289552.
Crossref
Jianpeng Liu, Wei Xi, Jiahao Zhou, Wei Gao & Qiaolin Wu. (2023) Nomogram predicting overall prognosis for invasive micropapillary carcinoma of the breast: a SEER-based population study. BMJ Open 13:8, pages e072632.
Crossref
Yajun Miao & Jun Liu. (2023) Tumor-suppressive action of miR-30a-5p in lung adenocarcinoma correlates with ABL2 inhibition and PI3K/AKT pathway inactivation. Clinical and Translational Oncology 26:2, pages 398-413.
Crossref
Liusheng Wu, Qi Liu, Xin Ruan, Xinyu Luan, Yanfeng Zhong, Jixian Liu, Jun Yan & Xiaoqiang Li. (2023) Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD). Biomedicines 11:7, pages 1861.
Crossref
Zi Chen, Linyang Ge, Shuanglan Xu, Qin Li & Linfu Zhou. (2023) A novel defined pyroptosis-related gene signature predicts prognosis and correlates with the tumour immune microenvironment in lung adenocarcinoma. Scientific Reports 13:1.
Crossref
Lihong Yang, Yazhou Cui, Lu Liang & Jianping Lin. (2023) Significance of cuproptosis‐related lncRNA signature in LUAD prognosis and immunotherapy: A machine learning approach . Thoracic Cancer.
Crossref
Yi Yang, Xiaoli Wang, Jin Lu, Zhiyong Dong, Ruixiang Hu, Wenhui Chen, Songhao Hu, Guanhua Lu, Biao Huang, Shiliang Dong, Lu Wang & Cunchuan Wang. (2023) Construction of a Prognostic Model for Predicting Colorectal Cancer Prognosis and Response to Immunotherapy Based on Cuproptosis-Associated lncRNAs. Journal of Oncology 2023, pages 1-16.
Crossref
Liangbo Dong, Shengnan Zhou, Xuesong Bai & Xiaodong He. (2023) Construction of a prognostic model for HCC based on ferroptosis-related lncRNAs expression and its potential to predict the response and irAEs of immunotherapy. Frontiers in Pharmacology 14.
Crossref
Jie Zeng, Zhenyu Wu, Meijuan Luo, Xie Xu, Wenjie Bai, Guijing Xie, Quhai Chen, Dengfeng Liang, Zixun Xu, Mindong Chen & Jianjiang Xie. (2023) Development and validation of an endoplasmic reticulum stress long non-coding RNA signature for the prognosis and immune landscape prediction of patients with lung adenocarcinoma. Frontiers in Genetics 14.
Crossref
Guan-Zhan Liang, Xiao-Feng Wen, Yi-Wen Song, Zong-Jin Zhang, Jing Chen, Yong-Le Chen, Wei-Dong Pan, Xiao-Wen He, Tuo Hu & Zhen-Yu Xian. (2023) Construction and Validation of a Novel Prognosis Model in Colon Cancer Based on Cuproptosis-Related Long Non-Coding RNAs. Journal of Clinical Medicine 12:4, pages 1528.
Crossref
Linfeng Li, Qidong Cai, Zeyu Wu, Xizhe Li, Wolong Zhou, Liqing Lu, Bin Yi, Ruimin Chang, Heng Zhang, Yuanda Cheng, Chunfang Zhang & Junjie Zhang. (2023) Bioinformatics construction and experimental validation of a cuproptosis-related lncRNA prognostic model in lung adenocarcinoma for immunotherapy response prediction. Scientific Reports 13:1.
Crossref
Qianrong HuangJun YanQian JiangFangzhou GuoLigen MoTeng Deng. (2023) Construction of a pyroptosis-related lncRNAs signature for predicting prognosis and immunotherapy response in glioma. Medicine 102:6, pages e32793.
Crossref
Shuting Meng, Tianye Zhu, Zhiwei Fan, Yulan Cheng, Yefeng Dong, Fengxu Wang, Xuehai Wang, Deping Dong, Songtao Yuan & Xinyuan Zhao. (2023) Integrated single-cell and transcriptome sequencing analyses develops a metastasis-based risk score system for prognosis and immunotherapy response in uveal melanoma. Frontiers in Pharmacology 14.
Crossref
Shaoyong Liu, Changming Zhai, Qiuyue Jiang, Wei Wang & Lu You. (2023) Bioinformatics Analysis Based on Iron Death-Related LncRNAs: Construction of a Clinical Prognostic Model for Lung Adenocarcinoma and Correlation Analysis of Immune Infiltration. Journal of Biomedical Nanotechnology 19:2, pages 299-308.
Crossref
Shulian Zeng, Wenjun Li, Hao Ouyang, Ying Xie, Xiaoqiang Feng & Li Huang. (2023) A Novel Prognostic Pyroptosis-Related Gene Signature Correlates to Oxidative Stress and Immune-Related Features in Gliomas. Oxidative Medicine and Cellular Longevity 2023, pages 1-28.
Crossref
Lingling Hong, Xuehai Wang, Weiming Cui, Fengxu Wang, Weiwei Shi, Shali Yu, Yonghua Luo, Lixin Zhong & Xinyuan Zhao. (2023) Construction of a ferroptosis scoring system and identification of LINC01572 as a novel ferroptosis suppressor in lung adenocarcinoma. Frontiers in Pharmacology 13.
Crossref
Qixuan Li, Yijie Tang, Tianyi Wang, Jiaqi Zhu, Youlang Zhou & Jiahai Shi. (2022) Novel immunogenic cell death-related risk signature to predict prognosis and immune microenvironment in lung adenocarcinoma. Journal of Cancer Research and Clinical Oncology 149:1, pages 307-323.
Crossref
Huang Di, Jiting Zhao, Xue Zhu, Xinpeng ZhouYuanlong Hu, Mengjie Wang, Zhanjun Qiu, Wei Zhang & Xianhai Chen. (2022) A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncRNAs: A Review. Medicine 101:49, pages e31924.
Crossref
Zina Cheng, Juechen Han, Fa Jiang, Weiyi Chen & Xiaolu Ma. (2022) Prognostic pyroptosis-related lncRNA signature predicts the efficacy of immunotherapy in hepatocellular carcinoma. Biochemistry and Biophysics Reports 32, pages 101389.
Crossref
Jiali Liang, Weifeng Jin & Huaping Xu. (2022) An efficient five-lncRNA signature for lung adenocarcinoma prognosis, with AL606489.1 showing sexual dimorphism. Frontiers in Genetics 13.
Crossref
Xi Chen, Jianzhang Wu & Jiabing Wang. (2022) Pyroptosis: A new insight of non-small-cell lung cancer treatment. Frontiers in Oncology 12.
Crossref
Guodong Wu, Dingwei Feng, Ziyu Zhang, Gao Zhang & Wei Zhang. (2022) Establishment of lung adenocarcinoma classification and risk model based on necroptosis-related genes. Frontiers in Genetics 13.
Crossref
Man Wang, Yuan Zhang, Wenguang Chang, Lei Zhang, Konstantinos N. Syrigos & Peifeng Li. (2022) Noncoding RNA-mediated regulation of pyroptotic cell death in cancer. Frontiers in Oncology 12.
Crossref
Qingtong Shi, Song Han, Xiong Liu, Saijian Wang & Haitao Ma. (2022) Integrated single-cell and transcriptome sequencing analyses determines a chromatin regulator-based signature for evaluating prognosis in lung adenocarcinoma. Frontiers in Oncology 12.
Crossref
Yue Xu, Tao Tao, Shi Li, Shuzhen Tan, Haiyan Liu & Xiao Zhu. (2022) Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma. Frontiers in Genetics 13.
Crossref
Junqing Qi, Jun Yin & Guowen Ding. (2022) A Connexin-Based Biomarker Model Applicable for Prognosis and Immune Landscape Assessment in Lung Adenocarcinoma. Journal of Oncology 2022, pages 1-12.
Crossref
Ya-Qiang Pan, Ying Xiao, Tao Long, Chao Liu, Wen-Hui Gao, Yang-Yong Sun, Chang Liu, Yi-Jun Shi, Shuang Li & Ai-Zhong Shao. (2022) Prognostic value of lncRNAs related to fatty acid metabolism in lung adenocarcinoma and their correlation with tumor microenvironment based on bioinformatics analysis. Frontiers in Oncology 12.
Crossref
Min Chen, Guang-Bo Wu, Shan Hua, Zhi-Feng Zhao, Hong-Jie Li & Meng Luo. (2022) Identification and validation of a prognostic model of necroptosis-related lncRNAs in hepatocellular carcinoma. Frontiers in Genetics 13.
Crossref
Yang Liu, Mingyang Yu, Xuechao Cheng, Xingshu Zhang, Qian Luo, Sijin Liao, Zhongzheng Chen, Jianhao Zheng, Kaijun Long, Xingwei Wu, Wendong Qu, Ming Gong & Yongxiang Song. (2022) A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs. Frontiers in Genetics 13.
Crossref
Yanfeng Chen, Zongbiao Tian, Hebin Hou & Wei Gai. (2022) The noncoding RNAs regulating pyroptosis in colon adenocarcinoma were derived from the construction of a ceRNA network and used to develop a prognostic model. BMC Medical Genomics 15:1.
Crossref
Jie Wu, Dingli Song, Guang Zhao, Sisi Chen, Hong Ren & Boxiang Zhang. (2022) Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients. Frontiers in Genetics 13.
Crossref
Ting Luo, Shiqun Yu, Jin Ouyang, Fanfan Zeng, Liyun Gao, Shaoxin Huang & Xin Wang. (2022) Identification of a apoptosis-related LncRNA signature to improve prognosis prediction and immunotherapy response in lung adenocarcinoma patients. Frontiers in Genetics 13.
Crossref
Fuling Mao, Zihao Li, Yongwen Li, Hua Huang, Zijian Shi, Xuanguang Li, Di Wu, Hongyu Liu & Jun Chen. (2022) Necroptosis-related lncRNA in lung adenocarcinoma: A comprehensive analysis based on a prognosis model and a competing endogenous RNA network. Frontiers in Genetics 13.
Crossref
Rui Sun, Xu Wang, Jiajie Chen, Da Teng, Shixin Chan, Xucan Tu, Zhenglin Wang, Xiaomin Zuo, Xiang Wei, Li Lin, Qing Zhang, Xiaomin Zhang, Kechao Tang, Huabing Zhang & Wei Chen. (2022) Development and validation of a novel cellular senescence-related prognostic signature for predicting the survival and immune landscape in hepatocellular carcinoma. Frontiers in Genetics 13.
Crossref
Jinhua Xiao, Yaxiang Wu, Pengran Paranggan, Weiyin Gao, Zhe Gao, Jialiang Liu & Lidong Wu. (2022) Involvement of plasma lncRNA GSEC in sepsis discrimination and prognosis, and its correlation with macrophage cell inflammation and proliferation. Immunobiology 227:5, pages 152264.
Crossref
Tingting Yin, Yin Yin & Lin Qu. (2022) Exploration of shared gene signature with development of pre-eclampsia and cervical cancer. Frontiers in Genetics 13.
Crossref
Dongjie Shi, Wenjie Zhong, Dan Liu, Xiaochuan Sun, Shilei Hao, Yaying Yang, Lei Ao, Junjie Zhou, Yongzhi Xia, Yudong Zhou, Hua Yu & Haijian Xia. (2022) Computational identification of immune-related lncRNA signature for predicting the prognosis and immune landscape of human glioblastoma multiforme. Frontiers in Immunology 13.
Crossref
Shuyi Zhou, Yuan Cai, Zhijie Xu, Bi Peng, Qiuju Liang, Jinwu Peng & Yuanliang Yan. (2022) Identification of a pyroptosis-related lncRNA signature in the regulation of prognosis, metabolism signals and immune infiltration in lung adenocarcinoma. Frontiers in Endocrinology 13.
Crossref
Xin Qi, Xingqi Chen, Yuanchun Zhao, Jiajia Chen, Beifang Niu & Bairong Shen. (2022) Prognostic Roles of ceRNA Network-Based Signatures in Gastrointestinal Cancers. Frontiers in Oncology 12.
Crossref
Zhaoshui Li, Zaiqi Ma, Hong Xue, Ruxin Shen, Kun Qin, Yu Zhang, Xin Zheng & Guodong Zhang. (2022) Chromatin Separation Regulators Predict the Prognosis and Immune Microenvironment Estimation in Lung Adenocarcinoma. Frontiers in Genetics 13.
Crossref
Xuan Zhou, Liangyu Yao, Xiang Zhou, Rong Cong, Jiaochen Luan, Xiyi Wei, Xu Zhang & Ninghong Song. (2022) Pyroptosis-Related lncRNA Prognostic Model for Renal Cancer Contributes to Immunodiagnosis and Immunotherapy. Frontiers in Oncology 12.
Crossref
HuiWei Chen, Zhimin Xie, QingZhu Li, GenYi Qu, NianXi Tan & YuLong Zhang. (2022) Risk coefficient model of necroptosis-related lncRNA in predicting the prognosis of patients with lung adenocarcinoma. Scientific Reports 12:1.
Crossref
Chuan Liu & Yongjie Wang. (2022) Identification of Two Subtypes and Prognostic Characteristics of Lung Adenocarcinoma Based on Pentose Phosphate Metabolic Pathway-Related Long Non-coding RNAs. Frontiers in Public Health 10.
Crossref
Yujian Xu, Youbai Chen, Zehao Niu, Jiahua Xing, Zheng Yang, Xiangye Yin, Lingli Guo, Qixu Zhang, Haixia Qiu & Yan Han. (2022) A Novel Pyroptotic and Inflammatory Gene Signature Predicts the Prognosis of Cutaneous Melanoma and the Effect of Anticancer Therapies. Frontiers in Medicine 9.
Crossref
Hua Huang, Zijian Shi, Yongwen Li, Guangsheng Zhu, Chen Chen, Zihe Zhang, Ruifeng Shi, Lianchun Su, Peijun Cao, Zhenhua Pan, Hongbing Zhang, Minghui Liu, Hongyu Liu & Jun Chen. (2022) Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis. Frontiers in Oncology 12.
Crossref
Cuifang Yang & Xiang Zheng. (2022) Identification of a Hypoxia-Related lncRNA Biomarker Signature for Head and Neck Squamous Cell Carcinoma. Journal of Oncology 2022, pages 1-13.
Crossref
Fada Xia, Yuanliang Yan & Cong Shen. (2021) A Prognostic Pyroptosis-Related lncRNAs Risk Model Correlates With the Immune Microenvironment in Colon Adenocarcinoma. Frontiers in Cell and Developmental Biology 9.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.